Anne Wyllie, assistant professor and associate research scientist at Yale School of Public Health, said she expects labs to charge about $10 for the SalivaDirect test.
developed by researchers at Yale in partnership and funding from the NBA and National Basketball Players Association was approved on SaturdayCalled SalivaDirect, the test uses saliva samples to detect COVID-19. SalivaDirect is non-invasive and requires just a small sample, reducing risks for healthcare workers collecting samples.
Anne Wyllie, assistant professor and associate research scientist at Yale School of Public Health, said she expects labs to charge about $10 for the test. In late June,There an altruistic component to SalivaDirect tests. The testing method is open source,"meaning that designated laboratories could follow the protocol to obtain the required components and perform the test in their lab according to Yale’s instructions for use," the FDA said in a statement.
When comparing results, SalivaDirect matched nasopharyngeal swab and other saliva testing methods at a 88%-94% rate, according to data cited by public health expert Andy Slavitt. Researchers have been looking for a COVID-19 test that is less invasive than the nasopharyngeal swabbing method and less expensive, which can lead to widespread testing and make up for shortages of other testing methods.
“Providing this type of flexibility for processing saliva samples to test for COVID-19 infection is groundbreaking in terms of efficiency and avoiding shortages of crucial test components like reagents,” FDA Commissioner Stephen M. Hahn said in a statement.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA approves COVID-19 saliva test developed at Yale in partnership with the NBA, NBPAA less invasive, saliva-based COVID-19 test developed by Yale researchers in partnership with the NBA and National Basketball Players Association has been approved by the FDA for emergency use.
Weiterlesen »
FDA grants emergency use authorization to quick, inexpensive saliva-based Covid-19 diagnostic testThe FDA grants emergency use authorization to a Covid-19 diagnostic test that uses a new, inexpensive method of processing saliva samples. The NBA was among the groups that funded the research.
Weiterlesen »
Britain lines up more potential COVID-19 vaccine supplies with J&J, Novavax dealsBritain will buy potential COVID-19 vaccines from U.S. drugmakers Johnson & Johnson and Novavax Inc , the companies said on Friday, boosting the number of deals it has with drugmakers as the global vaccine race rages on.
Weiterlesen »
Inside the multibillion dollar race for a Covid-19 vaccineThe world is betting on one thing to halt the pandemic: A vaccine. This is what it will take to bring one to the masses — and the key players behind those efforts.
Weiterlesen »
Opinion | What history tells us about a COVID-19 vaccine — and who it could failIf we do not design science and health care that benefits everyone, the enduring legacy of the pandemic will continue to be its terrible racial inequities.
Weiterlesen »